Meeting Banner
Abstract #1334

Developing a Delta Radiomics Framework for Prostate Cancer Progression Biomarkers in Patients under Active Surveillance: Pilot Study

Dyah Ekashanti Octorina Dewi1, Mohammed R. S. Sunoqrot1, Gabriel Addio Nketiah1, Elise Sandsmark2, Sverre Langørgen2, Helena Bertilsson3, Mattijs Elschot1,2, and Tone Frost Bathen1,2
1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway, 2Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway, 3Department of Urology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

Synopsis

Identification of progressive lesions over time is important to monitor the prostate cancer progression in active surveillance. Delta Radiomics, computed as the relative changes of features among scans, provides temporal evolution of features that may indicate clinical changes along time periods. This pilot study aims to develop a framework to identify progressive lesions on two long-term scans in prostate T2WI based on Delta-radiomics. The current results show that four Delta-radiomics features from GLDM and Shape feature groups have potentials to identify progressive lesions compared to other selected reproducible features.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords